Reported medication use in the neonatal intensive care unit: data from a large national data set

Area of Science:

• Neonatal intensive care
• Pharmacology
• Clinical research

Background:

• Neonatal intensive care units (NICUs) involve complex medication management.
• Understanding drug utilization patterns is crucial for optimizing neonatal care and research.
• Documentation methods can influence the perceived importance of specific medications.

Purpose of the Study:

• To identify the most frequently used drugs in NICU settings.
• To assess how drug documentation impacts research prioritization.
• To describe demographic variations in medication use.
• To identify medications associated with high-risk patient populations (>20% mortality).
• To analyze trends in medication utilization over time.

Main Methods:

• A retrospective analysis of a comprehensive national dataset was conducted.

Main Results:

• The top 10 NICU medications include ampicillin, gentamicin, and surfactant.
• Medications linked to >20% mortality populations include amphotericin, insulin, and epinephrine.
• Some drugs (e.g., amphotericin B) are used in extremely premature infants, potentially explaining high mortality.
• Other drugs (e.g., inhaled nitric oxide) are used in near-term/term infants, with high mortality possibly due to illness severity.
• Significant changes (>50%) in utilization rates were observed for drugs like metoclopramide and dexamethasone over the past five years.

Conclusions:

• This study provides the first large-scale national data on NICU medication use.
• Findings are essential for prioritizing future drug efficacy and safety studies in neonates.
• The data will inform evidence-based guidelines for neonatal pharmacotherapy.